Tromsoe

• An induction study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn's Disease Recruiting
  2025-521036-11-00 5 2026-03-23 Immune system disseases
• A Phase 2, Randomized, Double-Blind, Double-Dummy Study Evaluating the Efficacy, Safety and Biomarkers Effect of ILB® versus Riluzole in par … Recruiting
  2024-513927-18-00 4 2026-02-16 Amyotrophic Lateral Sclerosis
• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Platinum Resistant Ovarian Cancer Recruiting
  2024-514822-21-00 5 2025-10-02 Platinum-resistant Ovarian Cancer
• A clinical study of sacituzumab tirumotecan and pembrolizumab in people with endometrial cancer (MK-2870-033) Recruiting
  2024-519331-42-00 5 2025-08-22 pMMR endometrial carcinoma
• Metycor study Recruiting
  2024-514143-28-00 6 2025-08-01 Mild autonomous cortisol secretion
• A study to evaluate the efficacy of APG-2575 (Lisaftoclax) plus azacitidine (AZA) vs. placebo plus AZA in newly diagnosed adult subjects wit … Recruiting
  2024-517247-31-00 5 2025-07-07 Newly Diagnosed Higher Risk Myelodysplastic Syndrome
• Comprehensive Evaluation of Two Second-Line Therapeutic Approaches for Immune Thrombocytopenia (ITP) – a Pragmatic Randomized Controlled Tri … Recruiting
  2023-505573-32-00 5 2025-07-01 Immune Thrombocytopenia (ITP)
• Aminoglycosides in early sepsis Recruiting
  2024-519797-39-00 6 2025-07-01 Sepsis
• The Nordic Chronic Migraine Trial of CGRP monoclonal antibody and onabotulinumtoxin A dual therapy – a randomized-controlled double-blind tr … Recruiting
  2024-517981-40-00 5 2025-06-06 Chronic Migraine
• Precision cancer medicine in hard-to-treat rare cancers - repurposing drugs in earlier lines of treatment - MATRIX-RARE. Recruiting
  2024-513779-42-02 4 2025-03-27 Cancer
• Ketamine for depression and alcohol use disorder Recruiting
  2023-506052-24-00 9 2025-01-20 Depression
• Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl … Recruiting
  2023-506998-35-00 5 2025-01-08 Glioblastoma
• Assessment of short immunotherapy after radical surgery of high-risk malignant melanoma Recruiting
  2023-509994-22-00 5 2024-11-15 cutaneous malignant melanoma
• A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting
  2023-509560-16-00 5 2024-10-29 Juvenile psoriatic arthritis (jPsA)
• MOVE-JIA trial Recruiting
  2024-513017-12-00 6 2024-10-24 Juvenile Idiopathic Arthritis
• BORTEM 17 Recruiting
  2024-515142-16-00 7 2024-10-03 Grade IV recurrent glioma which includes both glioblastoma, classified
• The Effect of Topical Tranexamic Acid on Postoperative Complications in Soft Tissue Plastic Surgery. A Multicenter Randomized Controlled Tri … Recruiting
  2023-510381-28-01 6 2024-09-18 Patients undergoing plastic surgical procedures with wounds that would
• PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting
  2023-510415-19-00 4 2024-08-28 Acute Myeloid Leukemia
• Effect of proactive therapeutic drug monitoring on maintenance of sustained disease control in adults with rheumatoid arthritis on a subcuta … Recruiting
  2023-510184-35-00 6 2024-08-20 Rheumatoid arthritis
• Prospective comparison of sirolimus against corticosteroids in treatment of patients with active thyroid eye disease Recruiting
  2023-510166-27-01 5 2024-06-22 Thyroid eye disease
• A Placebo-Controlled, Randomized Double-Blind Parallel Group 12-Month Trial of Fasudil for the Treatment of Early Alzheimer’s Disease Recruiting
  2023-506514-44-00 4 2024-06-11 Alzheimer's disease
• A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting
  2023-506150-21-00 4 2024-05-29 Celiac Disease
• A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation compared to placebo in adult participants with Locally Advanced Un … Recruiting
  2023-508613-17-00 5 2024-05-29 Neoplasms, Head and Neck
• Atorvastatin in chronic migraine (StainMigChronic) Recruiting
  2022-502177-42-02 4 2024-05-13 Chronic migraine

Showing 25–48 of 122 trials